McKesson Corporation and Clayton Dubilier & Rice are finalizing a transformative acquisition of Option Care Health, valued at over $5 billion. This strategic deal represents a significant consolidation in the healthcare services sector, where undervalued infusion providers continue to attract institutional investors. The transaction underscores growing interest in consolidating fragmented healthcare delivery markets and improving operational efficiencies through scale and expertise.

Summary auto-generated by AI from the original publisher's content. Editorial standards.